Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ · Healthcare
Arcturus Therapeutics Holdings Inc. Shareholder Equity 2018–2025
Arcturus Therapeutics Holdings Inc. annual shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Arcturus Therapeutics Holdings Inc. shareholder equity as of December 31, 2025: 214.0M, a 11.20% decrease year-over-year.
- Arcturus Therapeutics Holdings Inc. shareholder equity for 2025 were 214.0M, a 11.20% decrease from 2024.
- Arcturus Therapeutics Holdings Inc. shareholder equity for 2024 were 241.0M, a 13.48% decrease from 2023.
- Arcturus Therapeutics Holdings Inc. shareholder equity for 2023 were 278.5M, a 3.03% increase from 2022.
- Arcturus Therapeutics Holdings Inc. shareholder equity for 2022 were 270.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Arcturus Therapeutics Holdings Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $214 |
| 2024 | $241 |
| 2023 | $279 |
| 2022 | $270 |
| 2021 | $228 |
| 2020 | $397 |
| 2019 | $26 |
| 2018 | $14 |
Arcturus Therapeutics Holdings Inc. Shareholder Equity — FAQ
Arcturus Therapeutics Holdings Inc. (ARCT) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARCT's shareholder equity history?
The chart and table above show Arcturus Therapeutics Holdings Inc.'s shareholder equity by year and by quarter, including the growth rate.